Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Chris Lavy led the first Africa Clubfoot Training (ACT) project training courses in Ethiopia last month, with an international team of orthopaedic surgeons and physiotherapists from the UK, Ethiopia, the Netherlands, Zimbabwe and Norway.

The team delivered a two-day basic provider course and one-day advanced provider course at the CURE Ethiopia Children's Hospital to train 31 surgical residents, doctors, physiotherapists, and nurses in the Ponseti method of clubfoot treatment.

The goal of the ACT project is to scale up clubfoot training capacity, not only in Ethiopia, but also across the region, so that more children born with clubfoot can access treatment.

Clubfoot is a common condition that occurs in approximately 1 in 700 births in Africa. If untreated, the condition deteriorates and children can be left with painful deformity.

ACT Training

The UK Department for International Development awarded the ACT project partners two years of funding in March 2015 through the Health Partnership Scheme to train more local instructors and to develop standardised clubfoot provider and instructor training materials for use throughout sub-Saharan Africa.

The University of Oxford (lead partner) are working with ACT project partners CURE Ethiopia Children's Hospital, the CURE Clubfoot Africa programme, and Global Clubfoot Initiative (a consortium of clubfoot provider and training organisations) to develop the resources, and also drawing on expertise from experienced clubfoot practitioners in the UK and Africa.

This course was the first of a series of pilot courses of the training materials which will continue through 2016, with the resources finalised by early 2017.

© Images courtesy of CURE Clubfoot

Similar stories

New children’s orthopaedic hospital opens in Zimbabwe

Main

A new children’s orthopaedic hospital in Bulawayo that will treat children across Zimbabwe who are living with musculoskeletal impairments has opened today.

Professor Katja Simon elected to the Academy of Medical Sciences

Awards Kennedy Main

Professor of Immunology Katja Simon has been elected as a Fellow of the Academy of Medical Sciences.

3,400 different medicines used globally to treat COVID-19

Main Statistics and epidemiology

Insufficient data, and misleading recommendations led to significant early heterogeneity in global COVID-19 patient management, according to recent BMJ study

Clinical trial finds Azithromycin has no benefit against COVID-19

Main OCTRU

A clinical trial by University of Oxford researchers has confirmed that the antibiotic azithromycin has no clinical benefit in people with moderate COVID-19.

Study reveals the three most important aspects of care for hip fractures

Hip Main OCTRU Research Trauma

Older patients with hip fractures recover better if they receive treatment under the supervision of both a surgeon and a specialist in elderly care; are checked to avoid future falls; and are assessed for memory problems.

Major ERC funding awarded to Professor Michael Dustin

Awards Kennedy Main

Professor Michael Dustin and an international team of collaborators have been awarded a €10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.